Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

Articles published in
Neuroscience
    March 2026
  1. SHEN X, Dong X, Nao J
    Harmine and its derivatives: A promising multi-target therapeutic avenue for Alzheimer's disease.
    Neuroscience. 2026;601:155-168.
    >> Share

    February 2026
  2. PANDA SP, Saraswat N, Singh V
    Gene therapy targeting synaptopathy linked with Alzheimer's and Parkinson's disease.
    Neuroscience. 2026 Feb 21:S0306-4522(26)00138.
    >> Share

  3. RIQUELME-CONTRERAS P, Henriquez F, Gonzalez-Campo C, Altschuler F, et al
    Impact of cardiometabolic factors and AD plasma biomarkers on white matter hyperintensities volume in individuals with cognitive complaints from the global south.
    Neuroscience. 2026;595:270-279.
    >> Share

  4. MINAURO-SANMIGUEL F, Vargas-Perez H
    Mitochondria-associated membranes and hallucinogenic therapy in Alzheimer's disease.
    Neuroscience. 2026 Feb 16:S0306-4522(26)00125.
    >> Share

  5. HE L, Xiaopeng Z, Juan D, Yan L, et al
    Anti-ASC antibodies alleviate Alzheimer's disease-type pathology in APP/PS1 mice.
    Neuroscience. 2026;599:152-161.
    >> Share

    January 2026
  6. DENVER P, Duffy A, Kennedy RT, Gault VA, et al
    Therapeutic efficacy of synthetic analogues of gut hormones in a mouse model of Alzheimer's disease.
    Neuroscience. 2026 Jan 28:S0306-4522(26)00075.
    >> Share

  7. ZHANG N, Wang S, Gui Y, Li D, et al
    TLR2 regulation of NF-kappaB and NLRP3-driven pyroptosis in Alzheimer's disease.
    Neuroscience. 2026 Jan 23:S0306-4522(26)00063.
    >> Share

  8. ZHOU L, Wang Z, Jiang Y, Wang M, et al
    A Mendelian randomization study with bioinformatics analysis reveals gut microbiota mediates in heart failure and Alzheimer's disease via BAFF-R.
    Neuroscience. 2026 Jan 22:S0306-4522(26)00046.
    >> Share

  9. YAN L, Wang H, Shi J, Tan H, et al
    Bibliometric analysis of neuroinflammation in Alzheimer's Disease: Insights from APP/PS1 mouse model research in the past two decades.
    Neuroscience. 2026 Jan 20:S0306-4522(26)00045.
    >> Share

  10. QIAO J, Zhou G, Wu S, Shang H, et al
    A multi-view DTI feature fusion framework for enhanced diagnosis of Alzheimer's disease.
    Neuroscience. 2026 Jan 20:S0306-4522(26)00049.
    >> Share

  11. BAJINKA O, Jallow L, Ozdemir G
    A multi-target therapeutic framework for Alzheimer's disease: an integrative mechanistic review.
    Neuroscience. 2026 Jan 9:S0306-4522(26)00016.
    >> Share

    December 2025
  12. JOSEPH J, Simi VR, Rashmi KM, Rashmi R, et al
    Complexity of olfactory-evoked EEG as an evidence-based marker of Alzheimer's disease.
    Neuroscience. 2025;594:224-239.
    >> Share

  13. AMELIMOJARAD M, AmeliMojarad M
    Antibody drug conjugates in Alzheimer's disease: emerging strategies and future directions.
    Neuroscience. 2025 Dec 20:S0306-4522(25)01220.
    >> Share

  14. IOANNIDOU E, Vavilis T, Bourtzos Z, Stamoula E, et al
    Corrigendum to "A review of the TGF-beta1 pathway in Alzheimer's disease and depression: Possible restoration potential of antidepressants" [Neuroscience 585 (2025) 429-440].
    Neuroscience. 2025;593:170.
    >> Share

  15. ZHOU W, Qu R, Luo W, Zhang H, et al
    Identification of cognitive brain diseases using a dual-branch siamese network on structural magnetic resonance imaging data.
    Neuroscience. 2025;591:83-92.
    >> Share

  16. HU K, Li C, Liu Y, Pan C, et al
    Arabinoxylan ameliorates memory deficits and amyloid pathology in male 5 x FAD mice via modulation of gut microbiota structure.
    Neuroscience. 2025;591:52-62.
    >> Share

  17. MEHMOOD A, Shahid F, Khan R, AlZu'bi H, et al
    A review of deep learning techniques in Alzheimer's disease with emphasis on data tools and transfer learning.
    Neuroscience. 2025;593:242-254.
    >> Share

  18. JOGESHWAR BK, Lu S, Nephew BC
    Neuroanatomical-based machine learning prediction of Alzheimer's Disease across sex and age.
    Neuroscience. 2025 Dec 14:S0306-4522(25)01177.
    >> Share

  19. SHENG J, Wang L, Zhang Q, Chien Chou JT, et al
    Integrating multimodal data to identify single nucleotide polymorphism-related biomarkers and regulatory mechanisms in Alzheimer's disease.
    Neuroscience. 2025 Dec 11:S0306-4522(25)01169.
    >> Share

  20. ELKANA O, Segal O, Beheshti I
    Beyond brain scans: verbal memory testing as an efficient cognitive biomarker for preclinical Alzheimer's disease.
    Neuroscience. 2025;593:8-17.
    >> Share

    November 2025
  21. KIM KJ, Villegas AL, Kelley AR, Labut EM, et al
    Sex differences in sleep fragmentation in 5xFAD mice.
    Neuroscience. 2025;589:118-127.
    >> Share

  22. MELCOP J, Ong JY, Ciaghi S, Keramopoulou M, et al
    Correlation of adult neurogenesis and cognitive performance in touchscreen tasks - assessing the novel small molecule OXS-N1 in mice.
    Neuroscience. 2025;589:322-334.
    >> Share

  23. ALI S, Kosar S, Sina RM, Sima A, et al
    Serum bile acids and brain hypometabolism in patients across Alzheimer's disease continuum: An [(18)F]FDG-PET study.
    Neuroscience. 2025 Nov 6:S0306-4522(25)01063.
    >> Share

    October 2025
  24. VANYA, Kumari S, Bagri K, Deshmukh R, et al
    Tangles and Plaques: A deep dive into the pathological hallmarks of Alzheimer's disease.
    Neuroscience. 2025 Oct 30:S0306-4522(25)01048.
    >> Share

  25. DAS R, Chatterjee A, Roy S
    An interpretable Bayesian framework for Alzheimer's disease prediction with uncertainty quantification.
    Neuroscience. 2025 Oct 15:S0306-4522(25)01013.
    >> Share

  26. ELAMIN SA, Al Shibli AN, Shaito A, Al-Maadhadi MJMB, et al
    Anti-amyloid monoclonal antibody therapies in Alzheimer's disease - a scoping review.
    Neuroscience. 2025 Oct 10:S0306-4522(25)01003.
    >> Share

  27. ESCOBAR-LOPEZ M, Salazar-Varas R
    Analysis of EEG coherence according to the onset of Alzheimer's disease.
    Neuroscience. 2025 Oct 10:S0306-4522(25)00979.
    >> Share

    September 2025
  28. CHAUHAN P, Vadia N, Ballal S, Joshi KK, et al
    Decoding the neuroprotective potential of hesperidin: Insights into Alzheimer's disease.
    Neuroscience. 2025 Sep 20:S0306-4522(25)00954.
    >> Share

  29. ALSHEHRI ZS
    Integrating artificial intelligence with small molecule therapeutics and precision medicine for neurochemical understanding of Alzheimer's diseases.
    Neuroscience. 2025;586:44-57.
    >> Share

  30. IQBAL A, Iqbal K, Shah YA, Ullah F, et al
    Multi-filter stacking in inception V3 for enhanced Alzheimer's severity classification.
    Neuroscience. 2025;586:21-31.
    >> Share

  31. ELENI I, Theofanis V, Zisis B, Eleni S, et al
    A review of the TGF-beta1 pathway in Alzheimer's disease and depression: Possible restoration potential of antidepressants.
    Neuroscience. 2025 Sep 12:S0306-4522(25)00925.
    >> Share

  32. SHENG J, Wang J, Zhang Q, Huang R, et al
    Cognitive prediction using regional connectivities and network biomarkers in Alzheimer's disease.
    Neuroscience. 2025 Sep 3:S0306-4522(25)00907.
    >> Share

  33. AKAN T, Akan S, Alp S, Ledbetter CR, et al
    AlzFormer: Video-based space-time attention model for early diagnosis of Alzheimer's disease.
    Neuroscience. 2025 Sep 3:S0306-4522(25)00910.
    >> Share

  34. LAYAL H, Rajbongshi J, Kumar R, Pandey S, et al
    Hydrogen sulfide in the brain as a silent neuroprotector in Alzheimer's disease.
    Neuroscience. 2025 Sep 2:S0306-4522(25)00905.
    >> Share

    August 2025
  35. BARROSO DE SOUSA D, Clara Ribeiro Zucato HM, Ribeiro HM, Alexandre-Silva V, et al
    Interplay between depressive symptoms and Alzheimer's disease dementia: unraveling the potential roles of ADAM10 and Negr1.
    Neuroscience. 2025 Aug 12:S0306-4522(25)00848.
    >> Share

  36. YANG Y, Ji Q, Cao JJ, Zhang YJ, et al
    Overactivation of the inward rectifier K(+) channel 2.1 modulates intrinsic excitability of adult-born granule cells in the male Alzheimer's APP/PS1 mouse model.
    Neuroscience. 2025 Aug 9:S0306-4522(25)00845.
    >> Share

    July 2025
  37. XU Y, Zhang Z, Peng J, Li X, et al
    Use of magnetic resonance structural imaging to identify disease progression in patients with mild cognitive impairment: A voxel-based morphometry and surface-based morphometry study.
    Neuroscience. 2025;579:382-389.
    >> Share

  38. NI L, Lin L, Zhao W, Li Y, et al
    Differences in patterns of functional and structural connectivity alterations of hippocampal subregions in patients on the Alzheimer's disease spectrum.
    Neuroscience. 2025 Jul 19:S0306-4522(25)00807.
    >> Share

  39. AVILA J, Hernandez F, Perry G
    Amyloid and tau pathologies cross-talk to promote Alzheimers disease: novel mechanistic insights.
    Neuroscience. 2025;582:58-62.
    >> Share

  40. KANG X, Tian J, Shu Q, Cheng T, et al
    Microglia-neuron crosstalk in Alzheimer's disease: an exploration of molecular mechanisms and pathological implications.
    Neuroscience. 2025 Jul 10:S0306-4522(25)00781.
    >> Share

  41. NASIRI H, Azargoonjahromi A
    Response to "Reevaluating leucine's effects on Alzheimer's disease: evidence of potential benefits overlooked".
    Neuroscience. 2025 Jul 5:S0306-4522(25)00768.
    >> Share

    June 2025
  42. WANG G, Ma T, Liu R, Gu H, et al
    Comparisons of metabolites and gut microbiota profiles for both young and middle-aged APPSwe/PS1De9 mice.
    Neuroscience. 2025;577:54-63.
    >> Share

  43. SATHIAN B, Iqbal J, Al Hamad H
    Reevaluating Leucine's effects on Alzheimer's disease: evidence of potential benefits overlooked.
    Neuroscience. 2025;579:121.
    >> Share

    May 2025
  44. YANG Q, Huang D, Zhang Z, Gao H, et al
    Diabetes affects AD through plasma Abeta40: A Mendelian randomization study.
    Neuroscience. 2025;575:131-139.
    >> Share

  45. NASIRI H, Azargoonjahromi A, Nouri Z, Azimi SM, et al
    Elevated serum leucine levels are associated with cognitive impairment and reduced gray matter and cerebral volume across the Alzheimer's disease continuum.
    Neuroscience. 2025;577:47-53.
    >> Share

  46. AATHIRA NS, Kaur A, Kumar A, Dar GM, et al
    The genetic risk factors, molecular pathways, microRNAs, and the gut microbiome in Alzheimer's disease.
    Neuroscience. 2025 May 13:S0306-4522(25)00373.
    >> Share

  47. GALAL A, Moustafa A, Salama M
    Transforming neurodegenerative disorder care with machine learning: Strategies and applications.
    Neuroscience. 2025;573:272-285.
    >> Share

  48. MORAIS RF, Pires R, Jesus T, Lemos R, et al
    Cognitive impairment in neurodegenerative diseases: A trans-diagnostic approach using a lesion-symptom mapping analysis.
    Neuroscience. 2025;573:214-227.
    >> Share

    April 2025
  49. ZHANG R, Sheng J, Zhang Q, Wang J, et al
    A review of multimodal fusion-based deep learning for Alzheimer's disease.
    Neuroscience. 2025;576:80-95.
    >> Share

  50. JAIN S, Srivastava R
    Enhanced EEG-based Alzheimer's disease detection using synchrosqueezing transform and deep transfer learning.
    Neuroscience. 2025;576:105-117.
    >> Share

  51. JOLIVALT CG, Calcutt NA, Masliah E
    Corrigendum to "Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer's disease" [Neuroscience 202 (2012) 405-412].
    Neuroscience. 2025;575:94.
    >> Share

  52. ROY KK, Mehta DK, Das R
    Reevaluating Alzheimer's disease treatment: Can phytochemicals bridge the therapeutic Gap?
    Neuroscience. 2025;575:1-18.
    >> Share

  53. KHANDAYATARAY P, Murthy MK
    Exploring the nexus: Sleep disorders, circadian dysregulation, and Alzheimer's disease.
    Neuroscience. 2025;574:21-41.
    >> Share

  54. KAUR A, Aran KR
    Unraveling the cGAS-STING pathway in Alzheimer's disease: A new Frontier in neuroinflammation and therapeutic strategies.
    Neuroscience. 2025;573:430-441.
    >> Share

    March 2025
  55. SHAH FA, Qadir H, Khan JZ, Faheem M, et al
    A review: From old drugs to new solutions: The role of repositioning in alzheimer's disease treatment.
    Neuroscience. 2025 Mar 29:S0306-4522(25)00266.
    >> Share

  56. LAU F, Binacchi R, Brugnara S, Cumplido-Mayoral A, et al
    Using Single-Cell RNA sequencing with Drosophila, Zebrafish, and mouse models for studying Alzheimer's and Parkinson's disease.
    Neuroscience. 2025 Mar 26:S0306-4522(25)00244.
    >> Share

  57. CHEN J, Xu S, Wang L, Liu X, et al
    Refining the interactions between microglia and astrocytes in Alzheimer's disease pathology.
    Neuroscience. 2025;573:183-197.
    >> Share

  58. LI Y, Yang C, Liu X, Shu J, et al
    Potential therapeutic targets for Alzheimer's disease: Fibroblast growth factors and their regulation of ferroptosis, pyroptosis and autophagy.
    Neuroscience. 2025;573:42-51.
    >> Share

  59. YAN X, Wang E, Zhao M, Ma G, et al
    Microbial infection instigates tau-related pathology in Alzheimer's disease via activating neuroimmune cGAS-STING pathway.
    Neuroscience. 2025;572:122-133.
    >> Share

    February 2025
  60. WU M, Zhang R, Fu P, Mei Y, et al
    Disrupted astrocyte-neuron signaling reshapes brain activity in epilepsy and Alzheimer's disease.
    Neuroscience. 2025;570:132-151.
    >> Share

  61. KALRA P, Grewal AK, Khan H, Singh TG, et al
    Unscrambling the cellular and molecular threads of Neuroplasticity: Insights into Alzheimer's disease pathogenesis.
    Neuroscience. 2025 Feb 17:S0306-4522(25)00151.
    >> Share

    January 2025
  62. YU Y, Shen H, Qin Q, Wang J, et al
    The investigation of peripheral inflammatory and oxidative stress biomarkers in dementia with Lewy Bodies, compared with Alzheimer's Disease, and mild cognitive impairment.
    Neuroscience. 2025 Jan 10:S0306-4522(24)00764.
    >> Share

    December 2024
  63. WANG ZJ, Han WN, Chai SF, Li Y, et al
    Semaglutide promotes the transition of microglia from M1 to M2 type to reduce brain inflammation in APP/PS1/tau mice.
    Neuroscience. 2024;563:222-234.
    >> Share

  64. WOOD OWG, Yeung JHY, Palpagama TH, Turner C, et al
    Upregulated excitatory amino acid transporter 1 (EAAT1) expression in the human medial temporal lobe in Alzheimer's disease.
    Neuroscience. 2024 Dec 16:S0306-4522(24)00734.
    >> Share

  65. APARAJITA A, Jain U, Srivastava P
    "Current and emerging drug therapies in Alzheimer's disease: A pathophysiological Perspective".
    Neuroscience. 2024;565:499-518.
    >> Share

  66. FANG H, Tian H, Liu J, Peng T, et al
    Ginsenoside Rg1 attenuates Abeta(1-42)-induced microglial cell apoptosis and inflammation in Alzheimer's disease via the GATA4/PDE4A/PI3K/AKT axis.
    Neuroscience. 2024;565:377-385.
    >> Share

  67. LI C, Wang S, Xia Y, Shi F, et al
    Risk factors and predictive models in the progression from MCI to Alzheimer's disease.
    Neuroscience. 2024;565:312-319.
    >> Share

    November 2024
  68. MOHAMMAD HOSSEINI A, Khaleghzadeh-Ahangar H, Rahimi A
    The immunomodulatory effects of psychedelics in Alzheimer's disease-related dementia.
    Neuroscience. 2024 Nov 25:S0306-4522(24)00651.
    >> Share

  69. ZHENG Y, Yu X, Li W, Wu F, et al
    HLA is a potent immunoinflammatory target in asymptomatic Alzheimer's disease.
    Neuroscience. 2024 Nov 19:S0306-4522(24)00638.
    >> Share

  70. CAO W, Zhu B, Liu Z, Jia X, et al
    Comparison of the efficacy of updated drugs for the treatment on the improvement of cognitive function in patients with Alzheimer 's disease: A systematic review and network meta- analysis.
    Neuroscience. 2024 Nov 14:S0306-4522(24)00611.
    >> Share

  71. KHANDAYATARAY P, Murthy MK
    Dietary interventions in mitigating the impact of environmental pollutants on Alzheimer's disease - A review.
    Neuroscience. 2024 Nov 12:S0306-4522(24)00602.
    >> Share

  72. YUAN J, Dong X, Zhou S, Nao J, et al
    Pharmacological activities and therapeutic potential of Hyperoside in the treatment of Alzheimer's and Parkinson's diseases: A systemic review.
    Neuroscience. 2024 Nov 1:S0306-4522(24)00565.
    >> Share

    October 2024
  73. SCARPA JR, Mincer JS
    Chronic pain-induced methylation in the prefrontal cortex targets gene networks associated with cognition and Alzheimer's disease.
    Neuroscience. 2024 Oct 15:S0306-4522(24)00519.
    >> Share

  74. ZHOU J, Gong L, Liu X, Chen L, et al
    Mendelian randomization in Alzheimer's disease and mild cognitive impairment: Hippocampal volume associations.
    Neuroscience. 2024 Oct 3:S0306-4522(24)00510.
    >> Share

  75. SINGH R, Joshi A, Koundal M, Sabharwal A, et al
    Proteomic insights into early-stage Alzheimer's disease: Identifying key neuronal proteins impacted by amyloid beta oligomers in an in vitro model.
    Neuroscience. 2024 Oct 1:S0306-4522(24)00503.
    >> Share

    August 2024
  76. GUTIERREZ RICO E, Joseph P, Noutsos C, Poon K, et al
    Hypothalamic and hippocampal transcriptome changes in App(NL-G-F) mice as a function of metabolic and inflammatory dysfunction.
    Neuroscience. 2024;554:107-117.
    >> Share

  77. SOHN E, Lim HS, Jin Kim Y, Kim BY, et al
    Exploring the therapeutic potential of Potentilla fragarioides var. major (Rosaceae) extract in Alzheimer's disease using in vitro and in vivo models: a multi-faceted approach.
    Neuroscience. 2024 Aug 21:S0306-4522(24)00427.
    >> Share

  78. E R SIMMATIS L, Russo EE, Altug Y, Murugathas V, et al
    Towards discovery and implementation of neurophysiologic biomarkers of Alzheimer's disease using entropy methods.
    Neuroscience. 2024 Aug 18:S0306-4522(24)00403.
    >> Share

  79. CHEN J, Peng G, Sun B
    Alzheimer's disease and sleep disorders: A bidirectional relationship.
    Neuroscience. 2024;557:12-23.
    >> Share

    July 2024
  80. XIANG LY, Chen XY, Lu LM, Kong MH, et al
    Mechanisms of Neuronal Reactivation in Memory Consolidation: A Perspective from Pathological Conditions.
    Neuroscience. 2024;551:196-204.
    >> Share

  81. BHATT A, Bhardwaj H, Shrivastava P
    Mesenchymal stem cell therapy for Alzheimer's disease: A novel therapeutic approach for neurodegenerative diseases.
    Neuroscience. 2024 Jul 18:S0306-4522(24)00332.
    >> Share

    June 2024
  82. AHMAD RATHER M, Khan A, Jahan S, Jamal Siddiqui A, et al
    Influence of Tau on neurotoxicity and cerebral vasculature impairment associated with Alzheimer's disease.
    Neuroscience. 2024 Jun 11:S0306-4522(24)00252.
    >> Share

    April 2024
  83. DENG J, Liu B, Tao Q, Luo Y, et al
    The co-oligomers of Abeta42 and human islet amyloid polypeptide exacerbate neurotoxicity and Alzheimer-like pathology at cellular level.
    Neuroscience. 2024 Apr 9:S0306-4522(24)00155.
    >> Share

    March 2024
  84. W G WOOD O, Walby J, Yeung JH, Ke S, et al
    Alzheimer's disease-associated region-specific decrease of vesicular glutamate transporter immunoreactivity inthe medial temporal lobe and superior temporal gyrus.
    Neuroscience. 2024 Mar 27:S0306-4522(24)00140.
    >> Share

  85. MEHMOOD A, Shahid F, Khan R, Ibrahim MM, et al
    Utilizing Siamese 4D-AlzNet and Transfer Learning to Identify Stages of Alzheimer's Disease.
    Neuroscience. 2024 Mar 14:S0306-4522(24)00112.
    >> Share

    February 2024
  86. XU M, Lin R, Wen H, Wang Y, et al
    Electroacupuncture Enhances the Functional Connectivity of Limbic System to Neocortex in the 5xFAD Mouse Model of Alzheimer's Disease.
    Neuroscience. 2024 Feb 27:S0306-4522(24)00090.
    >> Share

  87. ZHANG H, Yang Y, Zhang J, Huang L, et al
    Oligodendrocytes Play a Critical Role in White Matter Damage of Vascular Dementia.
    Neuroscience. 2024;538:1-10.
    >> Share

    January 2024
  88. QIAO Y, Liu H, He C, Ma Y, et al
    ApoE Mimic Peptide COG1410 Reduces Abeta Deposition and Improves Cognitive Function by Inducing the Transformation of A1/A2 Reactive Astrocytes and Increasing the BDNF Concentration in Brain of APP/PS1 Double Transgenic Mice.
    Neuroscience. 2024;537:116-125.
    >> Share

  89. ALIASHRAFI M, Nasehi M, Zarrindast MR, Joghataei MT, et al
    Intracerebroventricular Cutibacterium acnes generates manifestations of Alzheimer's disease-like pathology in the rat hippocampus.
    Neuroscience. 2024 Jan 22:S0306-4522(24)00023.
    >> Share

    November 2023
  90. WANG Q, Guo S, Hu D, Dong X, et al
    Enhanced GSDME-mediated pyroptosis in Alzheimer's disease.
    Neuroscience. 2023 Nov 7:S0306-4522(23)00491.
    >> Share

    September 2023
  91. ELDEEN MAKKI B, Rahman S
    Erratum to "Alzheimer's Disease in Diabetic Patients: A Lipidomic Prospect" [Neuroscience 530 (2023) 79-94].
    Neuroscience. 2023 Sep 26:S0306-4522(23)00427.
    >> Share

  92. LIU S, Zheng Y, Li H, Pan M, et al
    Improving Alzheimer Diagnoses with an interpretable Deep Learning Framework: including Neuropsychiatric Symptoms.
    Neuroscience. 2023 Sep 12:S0306-4522(23)00411.
    >> Share

    August 2023
  93. ELDEEN MAKKI B, Rahman S
    Alzheimer's Disease in Diabetic Patients: A Lipidomic Prospect.
    Neuroscience. 2023 Aug 29:S0306-4522(23)00402.
    >> Share

  94. WANG L, Wei Y, Sun Z, Jiang LH, et al
    DpdtpA, A Multi-metal Ion Chelator, Attenuates Tau Phosphorylation and Microglial Inflammatory Response via Regulating the PI3K/AKT/GSK-3beta Signal Pathways.
    Neuroscience. 2023;526:196-203.
    >> Share

  95. DENG LJ, Wu D, Yang XF, Li T, et al
    miR-146a-5p Modulates Adult Hippocampal Neurogenesis Deficits Through Klf4/p-Stat3 Signaling in APP/PS1 Mice.
    Neuroscience. 2023;526:314-325.
    >> Share

  96. LIN LL, Song GJ, Zhang H, Yin Y, et al
    GPR34 knockdown relieves cognitive deficits and suppresses neuroinflammation in Alzheimer's disease via the ERK/NF-kappaB signal.
    Neuroscience. 2023 Aug 7:S0306-4522(23)00342.
    >> Share

  97. YANG P, Liao C, Hu Q, Zhang J, et al
    Benzene, 1,2,4-Trimethoxy-5-(2-Methyl-1-Propen-1-yl) Attenuates D-galactose/AlCl(3)-induced Cognitive Impairment by Inhibiting Inflammation, Apoptosis, and improving Expression of Memory-Related Proteins.
    Neuroscience. 2023;524:242-255.
    >> Share

    June 2023
  98. WANG H, Zhang Z, Sittirattanayeungyong S, Hongpaisan J, et al
    ApoE4-related microvascular disease in the Alzheimer's disease hippocampal CA1 stratum radiatum.
    Neuroscience. 2023 Jun 27:S0306-4522(23)00289.
    >> Share

  99. GUNAWARDENA R, Sarrigiannis PG, Blackburn DJ, He F, et al
    Kernel-based Nonlinear Manifold Learning for EEG-based Functional Connectivity Analysis and Channel Selection with Application to Alzheimer's Disease.
    Neuroscience. 2023 Jun 8:S0306-4522(23)00253.
    >> Share

  100. LI Y, Fan H, Ni M, Zhang W, et al
    Targeting lncRNA NEAT1 hampers Alzheimer's disease progression.
    Neuroscience. 2023 Jun 5:S0306-4522(23)00103.
    >> Share

  101. FROST J, Schmitzer B, Topperwien M, Eckermann M, et al
    3d Virtual Histology Reveals Pathological Alterations of Cerebellar Granule Cells in Multiple Sclerosis.
    Neuroscience. 2023;520:18-38.
    >> Share

    May 2023
  102. MOLINERO N, Anton-Fernandez A, Hernandez F, Avila J, et al
    Gut Microbiota, an Additional Hallmark of Human Aging and Neurodegeneration.
    Neuroscience. 2023;518:141-161.
    >> Share

  103. FOUREST-LIEUVIN A, Vinit A, Blot B, Perrot A, et al
    Controlled Tau Cleavage in Cells Reveals Abnormal Localizations of Tau Fragments.
    Neuroscience. 2023;518:162-177.
    >> Share

  104. GALLO D, Ruiz A, Sanchez-Juan P
    Genetic Architecture of Primary Tauopathies.
    Neuroscience. 2023;518:27-37.
    >> Share

  105. JIMENEZ JS
    Macromolecular Structures and Proteins Interacting with the Microtubule Associated Tau Protein.
    Neuroscience. 2023;518:70-82.
    >> Share

  106. SCHULZ L, Ramirez P, Lemieux A, Gonzalez E, et al
    Tau-Induced Elevation of the Activity-Regulated Cytoskeleton Associated Protein Arc1 Causally Mediates Neurodegeneration in the Adult Drosophila Brain.
    Neuroscience. 2023;518:101-111.
    >> Share

  107. BERROCAL M, Mata AM
    The Plasma Membrane Ca(2+)-ATPase, a Molecular Target for Tau-induced Cytosolic Calcium Dysregulation.
    Neuroscience. 2023;518:112-118.
    >> Share

  108. CAAMANO-MORENO M, Gargini R
    Tauopathies: The Role of Tau in Cellular Crosstalk and Synaptic Dysfunctions.
    Neuroscience. 2023;518:38-53.
    >> Share

  109. ANDRES-BENITO P, Carmona M, Pirla MJ, Torrejon-Escribano B, et al
    Dysregulated Protein Phosphorylation as Main Contributor of Granulovacuolar Degeneration at the First Stages of Neurofibrillary Tangles Pathology.
    Neuroscience. 2023;518:119-140.
    >> Share

  110. CONCEPCION FA, Ekstrom NA, Khan MN, Estes OO, et al
    Progressive Dysregulation of Tau Phosphorylation in an Animal Model of Temporal Lobe Epilepsy.
    Neuroscience. 2023 May 2:S0306-4522(23)00193.
    >> Share

    April 2023
  111. KLEPL D, He F, Wu M, Blackburn DJ, et al
    Cross-Frequency Multilayer Network Analysis with Bispectrum-based Functional Connectivity: A Study of Alzheimer's Disease.
    Neuroscience. 2023 Apr 28:S0306-4522(23)00167.
    >> Share

  112. MURRAY HC, Saar G, Bai L, Bouraoud N, et al
    Progressive Spread of Beta-amyloid Pathology in an Olfactory-driven Amyloid Precursor Protein Mouse Model.
    Neuroscience. 2023;516:113-124.
    >> Share

    March 2023
  113. REN S, Li J, Huang L, Huang Q, et al
    Brain Functional Alterations and Association with Cognition in People with Preclinical Subjective Cognitive Decline and Objective Subtle Cognitive Difficulties.
    Neuroscience. 2023;513:137-144.
    >> Share

    February 2023
  114. PLACHEZ C, Tsytsarev V, Zhao S, Erzurumlu RS, et al
    Amyloid Deposition and Dendritic Complexity of Corticocortical Projection Cells in Five Familial Alzheimer's Disease Mouse.
    Neuroscience. 2023;512:85-98.
    >> Share

    October 2021
  115. VIARD A, Eustache F, Segobin S
    History of Magnetic Resonance Imaging: A Trip Down Memory Lane.
    Neuroscience. 2021;474:3-13.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016